NDC 57664-683-31 - Linezolid
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 57664-683
- Requested NDC
- 57664-683-31
- Package NDCs from labels
- 57664-683-31, 57664-683-57
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Effective date
- 2026-07-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Linezolid - Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries, Inc. | 2026-07-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57664-683-31 | Linezolid | 300 mL in 1 BAG | INJECTION, SOLUTION | 300 | 19 | |
| 57664-683-57 | Linezolid | 10 in 1 BOX | INJECTION, SOLUTION | 10 | 19 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 57664-683-31 | ML - Milliliter | 57664-683 | cca028ae-e970-41bc-b307-e39aa7924314 | 1 | 2017-09-11 |
| 57664-683-57 | ML - Milliliter | 57664-683 | 0b5a2567-f9b7-4cde-a5e8-fef439ffbf2a | 1 | 2017-09-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Infant Dextrose | DEXTROSE | Henry Schein, Inc. | ce71d929-d11e-444c-bd45-e025d5172057 | 2026-07-13 | Warnings, Adverse reactions | LX22YL083G |
| Linezolid | LINEZOLID | Eugia US LLC | b721756c-3b5e-456d-a2f6-0d8a56cc7f35 | 2026-07-13 | Warnings, Adverse reactions | 1662285 ISQ9I6J12J |
| Zyvox | LINEZOLID | Pharmacia & Upjohn Company LLC | 3e5e9975-6f36-42e4-ab46-0e75dda83592 | 2026-07-09 | Warnings, Adverse reactions | 1662285 ISQ9I6J12J |
| Linezolid | LINEZOLID | Mylan Pharmaceuticals Inc. | 83a84897-ccca-42a1-ab1a-bbf1d43a982b | 2026-07-09 | Warnings, Adverse reactions | ISQ9I6J12J |
| Linezolid | LINEZOLID | Sportpharm LLC | 7368298b-d75c-4950-bbc1-00fc53f472ec | 2026-07-02 | Warnings, Adverse reactions | ISQ9I6J12J |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fd8a72-0527-df0c-e063-6294a90abe75 | 2026-06-24 | LX22YL083G | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fddca1-b40c-7af0-e063-6294a90a410e | 2026-06-24 | LX22YL083G | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fdf83e-f641-1f69-e063-6394a90ab750 | 2026-06-24 | LX22YL083G | |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 672264e3-9709-4bba-2a9d-12bf70c7396a | 2026-06-24 | Warnings, Adverse reactions | LX22YL083G |
| Zyvox | LINEZOLID | Pharmacia & Upjohn Company LLC | 6e70e63b-bfd5-478d-a8ee-8ba22c9efabd | 2026-06-23 | Warnings, Adverse reactions | 1662278 1662285 ISQ9I6J12J |
| Linezolid | LINEZOLID | Hospira, Inc. | c401f1a8-cc37-461b-bfef-f2e156629bf8 | 2026-06-19 | Warnings, Adverse reactions | 1662285 ISQ9I6J12J |
| Linezolid | LINEZOLID | Sandoz Inc | a287cdf4-47a8-459f-8890-86181af5e836 | 2026-06-15 | Warnings, Adverse reactions | 1662278 1662285 ISQ9I6J12J |
| E-Z-GAS II | ANTACID/ANTIFLATULENT | E-Z-EM, INC. | 4e12e1cb-b033-076d-e054-00144ff8d46c | 2026-06-15 | Warnings | XF417D3PSL |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd. | 395aec48-198a-4aed-8e38-7accfb3232f9 | 2026-06-15 | Warnings, Adverse reactions | B22547B95K LX22YL083G |
| Linezolid | LINEZOLID | REMEDYREPACK INC. | 3e0d868d-f419-47e8-a3bc-41ececac468b | 2026-06-12 | Warnings, Adverse reactions | ISQ9I6J12J |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Cardinal Health 107, LLC | b3d5225c-0ee4-481e-b9ec-bc5e1321096d | 2026-06-12 | Adverse reactions | XF417D3PSL |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 | 2026-06-11 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 10e98cb0-31a5-4ad1-3eaa-aa4af387a42d | 2026-06-02 | Warnings, Adverse reactions | LX22YL083G |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Select Consumer Group | 3ca80d74-1e8b-49d9-e063-6394a90a4312 | 2026-05-24 | Warnings | XF417D3PSL |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | 8e255bc7-a120-460a-a32d-43931f8115de | 2026-05-21 | Warnings, Adverse reactions | B22547B95K LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.